Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink
- 916 Downloads
Antidepressant use has been associated with an increased risk of seizures. Evidence on the association between antidepressant use at therapeutic doses and seizures mainly comes from clinical trials that were not designed to investigate this potential relationship.
The objective of this study was to assess the risk of first-time seizures in association with exposure to antidepressants in patients with depressive disorders.
We conducted a retrospective follow-up study with a nested case–control analysis between 1998 and 2012, using data from the UK-based Clinical Practice Research Datalink (CPRD). We estimated crude incidence rates with 95 % confidence intervals (CIs) of seizures in depressed patients who used selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), ‘other antidepressants’, no antidepressants, or who had used antidepressants in the past. To adjust for potential confounding, we estimated odds ratios of antidepressant drug use among cases with seizures and matched controls in a nested case–control analysis.
Of 151,005 depressed patients, 619 had an incident seizure during follow-up. Incidence rates per 10,000 person-years were 12.44 (95 % CI 10.67–14.21) in SSRI users, 15.44 (95 % CI 8.99–21.89) in SNRI users, 8.33 (95 % CI 4.68–11.98) in TCA users, 9.33 (95 % CI 6.19–12.46) in non-users of antidepressants, and 5.05 (95 % CI 4.49–5.62) in past users of antidepressants. In the case–control analysis, relative risk estimates for seizures were increased in current users of SSRIs (adjusted odds ratio 1.98, 95 % CI 1.48–2.66) and SNRIs (adjusted odds ratio 1.99, 95 % CI 1.20–3.29), but not TCAs (adjusted odds ratio 0.99, 95 % CI 0.63–1.53), compared with non-users.
Current use of SSRIs or SNRIs was associated with a twofold increased risk of first-time seizures compared with non-use, while current use of TCAs (mostly low dose) was not associated with seizures. Treatment initiation in SSRI and SNRI users was associated with a higher risk of seizures than longer-term treatment.
KeywordsDepressed Patient Venlafaxine Index Date Duloxetine Mirtazapine
We thank Pascal Egger (Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland) for the programming and technical support.
Compliance with Ethical Standards
No sources of funding were used to assist in the preparation of this study.
Conflict of interest
Marlene Bloechliger, Alessandro Ceschi, Stephan Rueegg, Hugo Kupferschmidt, Stephan Kraehenbuehl, Susan S. Jick, Christoph R. Meier, and Michael Bodmer have no conflicts of interest that are directly related to the content of this study.
Study conception and design: Marlene Bloechliger, Alessandro Ceschi, Stephan Rueegg, Hugo Kupferschmidt, Stephan Kraehenbuehl, Susan S. Jick, Christoph R. Meier, and Michael Bodmer. Acquisition of data, guarantors for the study: Susan S. Jick and Christoph R. Meier. Analysis and interpretation of data: Marlene Bloechliger, Christoph R. Meier, Michael Bodmer. Drafting the manuscript: Marlene Bloechliger. Editing the manuscript: Alessandro Ceschi, Stephan Rueegg, Hugo Kupferschmidt, Stephan Kraehenbuehl, Susan S. Jick, Christoph R. Meier, and Michael Bodmer.
- 1.World Health Organization (WHO). Disease burden. Regional estimates for 2000–2011. 2013. http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index1.html. Accessed 18 Mar 2014.
- 3.National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and management. NICE guidance CG90. 2009. http://guidance.nice.org.uk/CG90/NICEGuidance/pdf/English. Accessed 24 Mar 2014.
- 4.Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller H-J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14:334–85.CrossRefPubMedGoogle Scholar
- 12.Köster M, Grohmann R, Engel RR, Nitsche MA, Rüther E, Degner D. Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008. Psychopharmacology (Berl). 2013;230:191–201.CrossRefPubMedGoogle Scholar
- 15.The Clinical Practice Research Datalink (CPRD). 2014. http://www.cprd.com. Accessed 9 Apr 2014.
- 19.Reed C, Hong J, Novick D, Lenox-Smith A, Happich M. Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database. Clinicoecon. Outcomes Res. 2013;5:37–47.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.World Health Organization WHO. ATC/DDD Index 2014. 2014. http://www.whocc.no/atc_ddd_index/. Accessed 31 Mar 2014.
- 38.Furukawa TA, McGuire H, Barbui C. Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev. 2003;(3):CD003197. doi: 10.1002/14651858.CD003197
- 41.Salzberg M. Neurobiological links between epilepsy and mood disorders. Neurol Asia. 2011;16(Suppl 1):37–40.Google Scholar